Pantham Ganesh, Post Anthony, Venkat Deepak, Einstadter Douglas, Mullen Kevin D
Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Division of Gastroenterology and Liver Diseases, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Dig Dis Sci. 2017 Aug;62(8):2166-2173. doi: 10.1007/s10620-017-4630-y. Epub 2017 May 30.
Overt hepatic encephalopathy (HE) is a major cause of significant morbidity and mortality in patients with liver cirrhosis. We examined the frequency and profile of the precipitating factors resulting in hospitalizations for overt HE.
We conducted both retrospective and prospective studies to identify clinical precipitants of overt HE in patients with cirrhosis. The retrospective study patients were hospitalized at a large urban safety-net hospital, and the prospective study included the patients admitted at a liver transplant center.
There were a total of 149 patients with cirrhosis and overt HE (91 males, mean age 55.3 ± 8.6 years) in the retrospective group and 45 patients (27 males, mean age 58.3 ± 8.2 years) in the prospective group of the study. The average MELD score was 16 ± 6.8 in the retrospective group and 22.7 ± 7.2 in the prospective group. Dehydration (46-76%), acute kidney injury (32-76%), lactulose nonadherence (about 50%), constipation (about 40%), and infections (20-42%) were the most frequently identified precipitants for hospitalization in retrospective and prospective groups. Multiple precipitants were identified in 60 (40.3%) patients in the retrospective group and 34 (76%) patients in the prospective group.
Multiple concurrent precipitating factors were identified in the majority of patients with overt HE requiring hospitalization. Dehydration due to various causes was the most common precipitant of overt HE, followed by acute kidney injury (AKI), constipation, and infections. Prevention of dehydration, AKI, and constipation by close outpatient monitoring may be an effective measure to prevent hospitalization for overt HE in patients with cirrhosis.
显性肝性脑病(HE)是肝硬化患者发病和死亡的主要原因。我们研究了导致显性HE患者住院的诱发因素的频率和特征。
我们进行了回顾性和前瞻性研究,以确定肝硬化患者显性HE的临床诱发因素。回顾性研究的患者在一家大型城市安全网医院住院,前瞻性研究包括在一家肝移植中心入院的患者。
回顾性研究组共有149例肝硬化和显性HE患者(91例男性,平均年龄55.3±8.6岁),前瞻性研究组有45例患者(27例男性,平均年龄58.3±8.2岁)。回顾性研究组的平均终末期肝病模型(MELD)评分是16±6.8,前瞻性研究组是22.7±7.2。脱水(46%-76%)、急性肾损伤(32%-76%)、不坚持服用乳果糖(约50%)、便秘(约40%)和感染(20%-42%)是回顾性和前瞻性研究组中最常确定的住院诱发因素。回顾性研究组60例(40.3%)患者和前瞻性研究组34例(76%)患者被确定有多种诱发因素。
大多数需要住院治疗的显性HE患者被确定有多种并发的诱发因素。各种原因导致的脱水是显性HE最常见的诱发因素,其次是急性肾损伤(AKI)、便秘和感染。通过密切的门诊监测预防脱水、AKI和便秘可能是预防肝硬化患者因显性HE住院的有效措施。